Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.
Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news 51Talk Online...
Good morning. This is peak season for shareholder letters, in which CEOs share observations about their results, priorities and views...
As several Indian pharma giants race to launch cheaper generics for Semaglutide, the active ingredient in popular weight-loss drugs Ozempic...
In a volatile global environment marked by elevated crude prices and geopolitical uncertainty, the Indian government’s decision to cut excise...
AI company Anthropic is developing and has begun testing with early access customers a new AI model more capable than...
Oil prices slipped in early Friday trade, capping a volatile week, after US President Donald Trump signalled progress in talks...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
